Logo image
Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease
期刊文章   開放取用(OA)   同儕審查

Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease

Shunsuke ChikumaJeffrey A. Bluestone
European Journal of Immunology, 卷.37(5), 頁碼.1285-1289
05/2007
PMID: 17429849

摘要

Autoimmunity Costimulation Tolerance Immunology and Allergy Immunology
Both CTLA-4-deficient and FoxP3-deficient mice exhibit a short life span due to massive lymphoproliferation (LP) and a systemic autoimmune-like syndrome. Although it has been postulated that both diseases result from regulatory T cell (T reg ) defects, there have been no direct complementation studies to elucidate their relationship in homeostatic lymphocyte proliferation during the neonatal period. In this study, reconstitution of sublethally irradiated RAG KO mice with either CTLA-4-deficient or FoxP3-deficient bone marrow (BM) resulted in LP disease similar to that observed in CTLA-4 KO or Scurfy mice, respectively. Although co-injection of BM from wild-type mice inhibited the activation of CTLA-4-deficient or FoxP3-deficient T cells and ameliorated LP disease through extrinsic regulatory mechanisms by T reg cells, mice that had received the BM mixture of Scurfy and CTLA-4 KO BM eventually died of incomplete protection. These results suggest common attributes of both diseases, but expression of both CTLA-4 and FoxP3 on the same cell subset is essential to fully prevent LP disease. © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

檔案與連結 (1)

url
https://doi.org/10.1002/eji.200737159檢視
已出版(紀錄版本) 開放

相關連結

指標

1 檢視次數

詳細資料

Logo image